Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective

Value in Health

Volumn 7, Issue 4, 2004, Pages 433-441

  Morales, Alvaro ^a   Martinez, Maria M ^b   Tasset Tisseau, Anne ^c   Rey, Elena ^d   Baron Papillon, Florence ^e   Follet, Alain ^e  

^a Fundacion Santafe de Bogota   (Colombia)

^b Banco Santander   (Colombia)

^c SANOFI PASTEUR   (France)

^d Aventis Pasteur   (Colombia)

^e MAPI VALUES   (United States)

Author keywords

Cost benefit; Influenza; Occupational health; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ADULT; ALLERGIC REACTION; COLOMBIA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMIC ASPECT; ECONOMIC EVALUATION; EDEMA; EMPLOYEE; EMPLOYER; ERYTHEMA; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INCOME; INFLUENZA; INFLUENZA VACCINATION; MALE; MYALGIA; NORMAL HUMAN; OBSERVATION; PAIN; PRIORITY JOURNAL; PRODUCTIVITY; PROSPECTIVE STUDY; PRURITUS; QUESTIONNAIRE; REVIEW; SENSITIVITY ANALYSIS; SOCIOECONOMICS; VACCINATION;

EID: 3843065431     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2004.74006.x     Document Type: Article

References (21)

1. Kilbourne ED, Arden NH. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3rd edn. Philadelphia: WB Saunders Company, 1999.
2. Perez-Tirse J, Gross P. Review of cost-benefit analyses of influenza vaccine. Pharmacoeconomics 1992;2:198-206.
3. Advisory Committee on Immunization Practices. Prevention and control of influenza. Part 1: Vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993;42(RR-6):1-14.
4. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy working adults. N Engl J Med 1995;333:889-93.
5. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. London: Blackwell Science Ltd., 1998.
6. Campbell DS, Rumley MH. Cost effectiveness of the influenza vaccine in a healthy working age population. J Occup Environ Med 1997;39:408-14.
7. Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in health care professionals. JAMA 1999;281:908-13.
8. Keech M, Scott AJ, Ryan PJJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Oxf) 1998;48:85-90.
9. Olsen GW, Burris JM, Burlew MM, et al. Absenteeism among employees who participated in a workplace influenza immunization program. J Occup Environ Med 1998;40:311-6.
10. Gardener P, Schaffner W. Immunisation in adults. N Engl J Med 1993;338:1252-8.
11. Postma MJ, Jansema P, van Genugten MLL, et al. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence. Drugs 2002;62:1013-24.
12. Akazawa M, Sindelar JL, Paltiel AD. Economic costs of influenza-related work absenteeism. Value Health 2003;6:107-15.
13. Das Gupta R, Guest JF. A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac® in the UK. Pharmacoeconomics 2002;20:475-84.
14. Lee PY, Matchar DB, Dennis A, et al. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 2002;137:225-31.
15. Demicheli V, Jefferson T, Rivetti D, et al. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;18:957-1030.
16. Nichol KL, Mallon KP, Medelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trail of trivalent live attenuated influenza vaccine. Vaccine 2003;3693:1-11.
17. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001;161:749-59.
18. Nichol KL. Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults. Vaccine 1999;17(Suppl.): S67-73.
19. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults. A randomised controlled trial. JAMA 2000;284:1655-63.
20. Dille JH. A worksite influenza program. Impact on lost work days, health care utilization, and health care spending. AAOHN J 1999;47:301-9.
21. Burckel E, Ashraf T, Galvão JP, et al. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company. Pharmacoeconomics 1999;16:563-76.